Clinical and economic burden of preseptal cellulitis in children: a 6-year review
Related Experiment Video
Updated: Mar 25, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Çağla Özbakır1, Deniz Ergün2, Pelin Kaçar2
1Department of Pediatrics, University of Health Sciences Dr. Behçet Uz Children's Hospital, İzmir, Türkiye.
Insights
Hospitalized children with preseptal cellulitis incur significant costs, primarily driven by length of stay. Understanding clinical factors is key to managing the economic burden of this common pediatric infection.
Area of Science:
- Pediatric infectious diseases
- Health economics
- Ophthalmology
Background:
- Preseptal cellulitis in children often leads to hospitalization, presenting clinical and economic challenges.
- Current data on pediatric preseptal cellulitis clinical characteristics and cost distribution are limited.
- Hospitalization involves intravenous antibiotics, imaging, lab tests, and consultations, increasing healthcare costs.
Purpose of the Study:
- To evaluate the clinical and economic burden of preseptal cellulitis in hospitalized children.
- To identify clinical factors associated with healthcare costs in pediatric preseptal cellulitis.
Main Methods:
- Retrospective study of 166 children (1 month to 18 years) hospitalized with preseptal cellulitis (Jan 2019-Dec 2024).
- Patients categorized by age and predisposing factors.
- Analysis of length of stay, total hospital costs, and cost components based on clinical characteristics.
Main Results:
- Most common symptoms included periorbital swelling (96.4%) and erythema (75.3%).
- Median length of stay was 5 days, with no significant differences across age, sex, or predisposing factors.
- A strong positive correlation (rho=0.775) was observed between length of stay and total hospital cost.
Conclusions:
- Length of stay is a significant predictor of total healthcare costs in pediatric preseptal cellulitis.
- Further research into cost-effective management strategies for pediatric preseptal cellulitis is warranted.
Background:
Children diagnosed with preseptal cellulitis frequently require hospitalization, leading to both clinical management challenges and substantial healthcare-related costs. The condition often necessitates intravenous antibiotic therapy, radiological imaging, laboratory tests, consultations, and inpatient care, which collectively contribute to the overall economic burden. However, data on the clinical characteristics and cost distribution among pediatric patients remain limited. This study aimed to evaluate both the clinical and economic burden of preseptal cellulitis in hospitalized children and to identify the clinical factors influencing healthcare costs.
Methods:
This retrospective study included children aged 1 month to 18 years who were hospitalized with a diagnosis of preseptal cellulitis between January 2019 and December 2024. Patients were grouped according to age and presence of predisposing factors. Length of stay, total hospital costs, and cost components were analyzed based on clinical characteristics.
Results:
A total of 166 patients were included (mean age: 70.1 ± 46.9 months; 62% male). The most common findings were periorbital swelling (96.4%) and erythema (75.3%). Median length of stay was 5 days, with no significant differences by age, sex, or predisposing factors (p>0.05). However, a strong positive correlation was found between length of stay and total cost (rho=0.775, p<0.001). The total hospital expenditure was 25,412.95 USD, with antibiotics accounting for the largest share (48.3%). Sinusitis and odontogenic infections were significantly associated with higher costs (p=0.007 and p=0.030). In multivariable analysis, length of stay, age, and odontogenic infection emerged as independent determinants of total cost, with costs increasing by approximately 15% per additional hospital day, 0.2% per month of age, and 25% in the presence of odontogenic infection.
Conclusion:
Developing standardized treatment protocols and promoting rational antibiotic use are critical for optimizing healthcare resource utilization and preventing antibiotic resistance.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Tonsillitis II: Management
Acne Infection
Staphylococcal Skin Infections
Viral Meningitis

